Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|May 19, 2012
The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphomaSarah L Hockley, Monica Else, Alison Morilla, et al.
Cancer|June 24, 2006
T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literatureNnenna Osuji, Estella Matutes, Geir Tjonnfjord, et al.
Haematologica|June 1, 2010
Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocationDavid Oscier, Rachel Wade, Zadie Davis, et al.
Leukemia & Lymphoma|December 17, 2002
Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemiaKellie A Benzow, Michael D Koob, Alison Condie, et al.
Blood|October 9, 2009
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemiaDalemari Crowther-Swanepoel, Mobshra Qureshi, Martin J S Dyer, et al.
Cancer|September 22, 2007
The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemiaMonica Else, Nnenna Osuji, Francesco Forconi, et al.
Blood|May 16, 2002
Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemiaMartin Yuille, Alison Condie, Chantelle Hudson, et al.
Genes, Chromosomes & Cancer|December 4, 2002
Delineation of the minimal region of loss at 13q14 in multiple myelomaManal O Elnenaei, Rifat A Hamoudi, John Swansbury, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 30, 2004
CD38 expression as a prognostic indicator in chronic lymphocytic leukaemiaPatrick D Thornton, Cristina Fernandez, Giada M Giustolisi, et al.
Blood|September 28, 2011
Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous routeClaire E Dearden, Amit Khot, Monica Else, et al.
Pageof 11